BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 18554637)

  • 21. P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis.
    Tempest HV; Dixon AK; Turner WH; Elneil S; Sellers LA; Ferguson DR
    BJU Int; 2004 Jun; 93(9):1344-8. PubMed ID: 15180635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder.
    Swana HS; Smith SD; Perrotta PL; Saito N; Wheeler MA; Weiss RM
    J Urol; 1999 Feb; 161(2):630-4. PubMed ID: 9915473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis.
    Dooley A; Low SY; Holmes A; Kidane AG; Abraham DJ; Black CM; Bruckdorfer KR
    Rheumatology (Oxford); 2008 Mar; 47(3):272-80. PubMed ID: 18238792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation.
    Han W; Fu S; Wei N; Xie B; Li W; Yang S; Li Y; Liang Z; Huo H
    Int J Cardiol; 2008 Nov; 130(2):165-73. PubMed ID: 18585800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation associated changes in gene expression profiles of interstitial cystitis and control urothelial cells.
    Erickson DR; Schwarze SR; Dixon JK; Clark CJ; Hersh MA
    J Urol; 2008 Dec; 180(6):2681-7. PubMed ID: 18951569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections.
    Smith SD; Wheeler MA; Foster HE; Weiss RM
    J Urol; 1996 Apr; 155(4):1432-5. PubMed ID: 8632605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.
    Slobodov G; Feloney M; Gran C; Kyker KD; Hurst RE; Culkin DJ
    J Urol; 2004 Apr; 171(4):1554-8. PubMed ID: 15017219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history.
    Seth A; Teichman JM
    J Urol; 2008 Nov; 180(5):2029-33. PubMed ID: 18804240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bladder microvasculature in women with interstitial cystitis.
    Rosamilia A; Cann L; Dwyer P; Scurry J; Rogers P
    J Urol; 1999 Jun; 161(6):1865-70. PubMed ID: 10332455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Glutamine inhibits interleukin-1beta induced nitric oxide production and inducible nitric oxide synthase expression: experiment with cultured rat hepatocytes].
    Lu J; Wang XY; Tang WH
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):695-8. PubMed ID: 19595066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity.
    Lokeshwar VB; Selzer MG; Unwala DJ; Estrella V; Gomez MF; Golshani R; Kester RR; Klumpp DJ; Gousse AE
    J Urol; 2006 Sep; 176(3):1001-7. PubMed ID: 16890679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cystoscopy in the diagnosis of Hunner's ulcer disease.
    Braunstein R; Shapiro E; Kaye J; Moldwin R
    J Urol; 2008 Oct; 180(4):1383-6. PubMed ID: 18707698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early changes in rectal nitric oxide and mucosal inflammatory mediators in Crohn's colitis in response to infliximab treatment.
    Ljung T; Axelsson LG; Herulf M; Lundberg JO; Hellström PM
    Aliment Pharmacol Ther; 2007 Apr; 25(8):925-32. PubMed ID: 17402996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis.
    Sun Y; Keay S; De Deyne PG; Chai TC
    J Urol; 2001 Nov; 166(5):1951-6. PubMed ID: 11586266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in rats.
    Giglio D; Ryberg AT; To K; Delbro DS; Tobin G
    Auton Neurosci; 2005 Oct; 122(1-2):9-20. PubMed ID: 16125470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis.
    Liu HT; Kuo HC
    Urology; 2007 Sep; 70(3):463-8. PubMed ID: 17905097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors.
    Liu M; Xu YF; Feng Y; Yang FQ; Luo J; Zhai W; Che JP; Wang GC; Zheng JH
    J Surg Res; 2013 Jul; 183(1):397-404. PubMed ID: 23260235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of inducible nitric oxide synthase: a protective mechanism in colitis-induced adenocarcinoma.
    Zhang R; Ma A; Urbanski SJ; McCafferty DM
    Carcinogenesis; 2007 May; 28(5):1122-30. PubMed ID: 17116728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis.
    Korting GE; Smith SD; Wheeler MA; Weiss RM; Foster HE
    J Urol; 1999 Feb; 161(2):558-65. PubMed ID: 9915448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.